Annual CFI
-$380.99 M
-$157.65 M-70.58%
31 March 2022
Summary:
Abiomed annual cash flow from investing activities is currently -$380.99 million, with the most recent change of -$157.65 million (-70.58%) on 31 March 2022. During the last 3 years, it has fallen by -$157.65 million (-70.58%).ABMD Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
$101.57 M
+$93.45 M+1151.75%
30 September 2022
Summary:
Abiomed quarterly cash flow from investing activities is currently $101.57 million, with the most recent change of +$93.45 million (+1151.75%) on 30 September 2022.ABMD Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$162.91 M
+$100.91 M+38.25%
30 September 2022
Summary:
Abiomed TTM cash flow from investing activities is currently -$162.91 million, with the most recent change of +$100.91 million (+38.25%) on 30 September 2022.ABMD TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABMD Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | -70.6% | +156.4% | +49.8% |
| 5 y5 years | -227.2% | +204.3% | +4.8% |
ABMD Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | -2623.9% | at high | -714.8% |
Abiomed Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | $101.57 M(+1151.8%) | -$162.91 M(-38.2%) |
| June 2022 | - | $8.11 M(-108.8%) | -$263.82 M(-30.8%) |
| Mar 2022 | -$380.99 M(+70.6%) | -$92.57 M(-48.6%) | -$380.99 M(+17.4%) |
| Dec 2021 | - | -$180.02 M(<-9900.0%) | -$324.66 M(+29.6%) |
| Sept 2021 | - | $660.00 K(-100.6%) | -$250.43 M(-27.7%) |
| June 2021 | - | -$109.06 M(+200.9%) | -$346.15 M(+55.0%) |
| Mar 2021 | -$223.34 M(+78.0%) | -$36.24 M(-65.7%) | -$223.34 M(+26.1%) |
| Dec 2020 | - | -$105.79 M(+11.3%) | -$177.14 M(+5.0%) |
| Sept 2020 | - | -$95.07 M(-791.1%) | -$168.76 M(+156.6%) |
| June 2020 | - | $13.76 M(+38.1%) | -$65.76 M(-47.6%) |
| Mar 2020 | -$125.45 M(+7.7%) | $9.96 M(-110.2%) | -$125.45 M(-26.7%) |
| Dec 2019 | - | -$97.41 M(-1328.9%) | -$171.17 M(+22.6%) |
| Sept 2019 | - | $7.93 M(-117.3%) | -$139.58 M(-29.2%) |
| June 2019 | - | -$45.94 M(+28.5%) | -$197.16 M(+69.3%) |
| Mar 2019 | -$116.45 M(-35.6%) | -$35.75 M(-45.7%) | -$116.45 M(-21.9%) |
| Dec 2018 | - | -$65.82 M(+32.6%) | -$149.16 M(+10.4%) |
| Sept 2018 | - | -$49.65 M(-242.8%) | -$135.05 M(+4.9%) |
| June 2018 | - | $34.77 M(-150.8%) | -$128.79 M(-28.8%) |
| Mar 2018 | -$180.76 M(+43.1%) | -$68.45 M(+32.4%) | -$180.76 M(-0.4%) |
| Dec 2017 | - | -$51.71 M(+19.2%) | -$181.53 M(+14.2%) |
| Sept 2017 | - | -$43.38 M(+152.1%) | -$158.92 M(+34.4%) |
| June 2017 | - | -$17.21 M(-75.1%) | -$118.21 M(-6.4%) |
| Mar 2017 | -$126.33 M(+118.9%) | -$69.22 M(+137.8%) | -$126.33 M(+45.7%) |
| Dec 2016 | - | -$29.11 M(+987.7%) | -$86.74 M(+3.3%) |
| Sept 2016 | - | -$2.68 M(-89.4%) | -$84.00 M(-5.4%) |
| June 2016 | - | -$25.33 M(-14.5%) | -$88.78 M(+53.8%) |
| Mar 2016 | -$57.71 M(+15.7%) | -$29.63 M(+12.4%) | -$57.71 M(+30.4%) |
| Dec 2015 | - | -$26.36 M(+253.6%) | -$44.25 M(+20.9%) |
| Sept 2015 | - | -$7.46 M(-229.9%) | -$36.61 M(-33.4%) |
| June 2015 | - | $5.74 M(-135.5%) | -$54.95 M(+10.2%) |
| Mar 2015 | -$49.86 M(+123.9%) | -$16.16 M(-13.7%) | -$49.86 M(+6.4%) |
| Dec 2014 | - | -$18.73 M(-27.4%) | -$46.85 M(+72.5%) |
| Sept 2014 | - | -$25.80 M(-338.3%) | -$27.16 M(+120.2%) |
| June 2014 | - | $10.83 M(-182.3%) | -$12.33 M(-44.6%) |
| Mar 2014 | -$22.27 M(+117.0%) | -$13.15 M(-1459.0%) | -$22.27 M(+64.3%) |
| Dec 2013 | - | $968.00 K(-108.8%) | -$13.56 M(+147.5%) |
| Sept 2013 | - | -$10.97 M(-1335.7%) | -$5.48 M(+88.4%) |
| June 2013 | - | $888.00 K(-120.0%) | -$2.91 M(-71.7%) |
| Mar 2013 | -$10.27 M(-41.3%) | -$4.44 M(-149.1%) | -$10.27 M(-17.1%) |
| Dec 2012 | - | $9.05 M(-207.7%) | -$12.38 M(-59.0%) |
| Sept 2012 | - | -$8.40 M(+29.9%) | -$30.21 M(+31.5%) |
| June 2012 | - | -$6.47 M(-1.3%) | -$22.98 M(+31.4%) |
| Mar 2012 | -$17.48 M(+643.2%) | -$6.56 M(-25.3%) | -$17.48 M(+56.4%) |
| Dec 2011 | - | -$8.78 M(+654.0%) | -$11.17 M(+42.3%) |
| Sept 2011 | - | -$1.17 M(+19.7%) | -$7.85 M(+36.0%) |
| June 2011 | - | -$973.00 K(+287.6%) | -$5.77 M(+145.5%) |
| Mar 2011 | -$2.35 M(-126.7%) | -$251.00 K(-95.4%) | -$2.35 M(+113.4%) |
| Dec 2010 | - | -$5.46 M(-697.8%) | -$1.10 M(-120.4%) |
| Sept 2010 | - | $914.00 K(-62.7%) | $5.40 M(-18.5%) |
| June 2010 | - | $2.45 M(+145.1%) | $6.63 M(-24.8%) |
| Mar 2010 | $8.82 M(-132.9%) | $999.00 K(-4.0%) | $8.82 M(-4.6%) |
| Dec 2009 | - | $1.04 M(-51.3%) | $9.25 M(+10.9%) |
| Sept 2009 | - | $2.14 M(-53.9%) | $8.34 M(-126.7%) |
| June 2009 | - | $4.64 M(+225.2%) | -$31.17 M(+16.3%) |
| Mar 2009 | -$26.80 M(-34.5%) | $1.43 M(+964.9%) | -$26.80 M(+5.5%) |
| Dec 2008 | - | $134.00 K(-100.4%) | -$25.41 M(-64.9%) |
| Sept 2008 | - | -$37.38 M(-514.9%) | -$72.41 M(+101.6%) |
| June 2008 | - | $9.01 M(+219.4%) | -$35.91 M(-12.2%) |
| Mar 2008 | -$40.91 M(-371.0%) | $2.82 M(-106.0%) | -$40.91 M(+6.6%) |
| Dec 2007 | - | -$46.87 M(+5250.1%) | -$38.36 M(-405.8%) |
| Sept 2007 | - | -$876.00 K(-121.8%) | $12.54 M(-3.5%) |
| June 2007 | - | $4.02 M(-25.2%) | $12.99 M(-13.9%) |
| Mar 2007 | $15.10 M | $5.37 M(+33.1%) | $15.10 M(+61.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2006 | - | $4.03 M(-1044.5%) | $9.37 M(+1219.4%) |
| Sept 2006 | - | -$427.00 K(-107.0%) | $710.00 K(-94.2%) |
| June 2006 | - | $6.12 M(-1805.0%) | $12.31 M(+67.1%) |
| Mar 2006 | $7.37 M(+284.6%) | -$359.00 K(-92.2%) | $7.37 M(-19.5%) |
| Dec 2005 | - | -$4.63 M(-141.4%) | $9.16 M(-38.4%) |
| Sept 2005 | - | $11.18 M(+849.5%) | $14.87 M(+316.2%) |
| June 2005 | - | $1.18 M(-17.7%) | $3.57 M(+86.4%) |
| Mar 2005 | $1.92 M(-106.6%) | $1.43 M(+31.9%) | $1.92 M(-131.3%) |
| Dec 2004 | - | $1.08 M(-1010.9%) | -$6.12 M(-81.5%) |
| Sept 2004 | - | -$119.00 K(-75.2%) | -$33.00 M(+7.1%) |
| June 2004 | - | -$479.00 K(-92.7%) | -$30.80 M(+5.4%) |
| Mar 2004 | -$29.23 M(-297.4%) | -$6.61 M(-74.4%) | -$29.23 M(+19.0%) |
| Dec 2003 | - | -$25.80 M(-1339.0%) | -$24.56 M(-568.6%) |
| Sept 2003 | - | $2.08 M(+90.8%) | $5.24 M(+257.7%) |
| June 2003 | - | $1.09 M(-156.3%) | $1.47 M(-90.1%) |
| Mar 2003 | $14.81 M(-157.7%) | -$1.94 M(-148.4%) | $14.81 M(-44.1%) |
| Dec 2002 | - | $4.01 M(-336.5%) | $26.50 M(+47.7%) |
| Sept 2002 | - | -$1.69 M(-111.7%) | $17.94 M(+19.6%) |
| June 2002 | - | $14.44 M(+48.1%) | $15.00 M(-158.4%) |
| Mar 2002 | -$25.68 M(+1895.6%) | $9.75 M(-314.2%) | -$25.68 M(-13.9%) |
| Dec 2001 | - | -$4.55 M(-1.7%) | -$29.81 M(+12.4%) |
| Sept 2001 | - | -$4.63 M(-82.4%) | -$26.52 M(+30.9%) |
| June 2001 | - | -$26.25 M(-567.1%) | -$20.26 M(+1474.3%) |
| Mar 2001 | -$1.29 M(-141.8%) | $5.62 M(-546.3%) | -$1.29 M(-69.6%) |
| Dec 2000 | - | -$1.26 M(-177.3%) | -$4.23 M(+138.9%) |
| Sept 2000 | - | $1.63 M(-122.4%) | -$1.77 M(-38.6%) |
| June 2000 | - | -$7.28 M(-371.8%) | -$2.88 M(-193.7%) |
| Mar 2000 | $3.08 M(-76.9%) | $2.68 M(+123.1%) | $3.08 M(-61.8%) |
| Dec 1999 | - | $1.20 M(+132.9%) | $8.06 M(-22.7%) |
| Sept 1999 | - | $515.20 K(-139.2%) | $10.42 M(+1.0%) |
| June 1999 | - | -$1.32 M(-117.2%) | $10.32 M(-22.4%) |
| Mar 1999 | $13.30 M(-171.9%) | $7.66 M(+115.0%) | $13.30 M(+35.2%) |
| Dec 1998 | - | $3.56 M(+770.3%) | $9.84 M(+1603.4%) |
| Sept 1998 | - | $409.40 K(-75.5%) | $577.70 K(-103.5%) |
| June 1998 | - | $1.67 M(-60.3%) | -$16.73 M(-9.6%) |
| Mar 1998 | -$18.50 M(+1056.3%) | $4.20 M(-173.7%) | -$18.50 M(-19.4%) |
| Dec 1997 | - | -$5.70 M(-66.3%) | -$22.94 M(+1.6%) |
| Sept 1997 | - | -$16.90 M(>+9900.0%) | -$22.59 M(<-9900.0%) |
| June 1997 | - | -$100.00 K(-59.1%) | $200.00 K(-112.5%) |
| Mar 1997 | -$1.60 M(-199.5%) | -$244.60 K(-95.4%) | -$1.60 M(>+9900.0%) |
| Dec 1996 | - | -$5.34 M(-190.8%) | -$6700.00(-100.1%) |
| Sept 1996 | - | $5.89 M(-409.9%) | $6.20 M(<-9900.0%) |
| June 1996 | - | -$1.90 M(-240.9%) | -$52.30 K(-103.3%) |
| Mar 1996 | $1.61 M(-329.8%) | $1.35 M(+55.7%) | $1.61 M(-317.4%) |
| Dec 1995 | - | $866.10 K(-335.9%) | -$740.00 K(-56.6%) |
| Sept 1995 | - | -$367.10 K(+53.6%) | -$1.71 M(-51.8%) |
| June 1995 | - | -$239.00 K(-76.1%) | -$3.54 M(+405.6%) |
| Mar 1995 | -$700.00 K(-122.6%) | -$1.00 M(+900.0%) | -$700.00 K(-187.5%) |
| Dec 1994 | - | -$100.00 K(-95.5%) | $800.00 K(-50.0%) |
| Sept 1994 | - | -$2.20 M(-184.6%) | $1.60 M(-55.6%) |
| June 1994 | - | $2.60 M(+420.0%) | $3.60 M(+16.1%) |
| Mar 1994 | $3.10 M(+675.0%) | $500.00 K(-28.6%) | $3.10 M(+416.7%) |
| Dec 1993 | - | $700.00 K(-450.0%) | $600.00 K(-57.1%) |
| Sept 1993 | - | -$200.00 K(-109.5%) | $1.40 M(-6.7%) |
| June 1993 | - | $2.10 M(-205.0%) | $1.50 M(+275.0%) |
| Mar 1993 | $400.00 K(-500.0%) | -$2.00 M(-233.3%) | $400.00 K(-81.8%) |
| Dec 1992 | - | $1.50 M(-1600.0%) | $2.20 M(+120.0%) |
| Sept 1992 | - | -$100.00 K(-110.0%) | $1.00 M(-68.8%) |
| June 1992 | - | $1.00 M(-600.0%) | $3.20 M(-3300.0%) |
| Mar 1992 | -$100.00 K(-101.9%) | -$200.00 K(-166.7%) | -$100.00 K(-200.0%) |
| Dec 1991 | - | $300.00 K(-85.7%) | $100.00 K(-150.0%) |
| Sept 1991 | - | $2.10 M(-191.3%) | -$200.00 K(-91.3%) |
| June 1991 | - | -$2.30 M | -$2.30 M |
| Mar 1991 | $5.20 M | - | - |
FAQ
- What is Abiomed annual cash flow from investing activities?
- What is the all time high annual CFI for Abiomed?
- What is Abiomed quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Abiomed?
- What is Abiomed TTM cash flow from investing activities?
- What is the all time high TTM CFI for Abiomed?
What is Abiomed annual cash flow from investing activities?
The current annual CFI of ABMD is -$380.99 M
What is the all time high annual CFI for Abiomed?
Abiomed all-time high annual cash flow from investing activities is $15.10 M
What is Abiomed quarterly cash flow from investing activities?
The current quarterly CFI of ABMD is $101.57 M
What is the all time high quarterly CFI for Abiomed?
Abiomed all-time high quarterly cash flow from investing activities is $101.57 M
What is Abiomed TTM cash flow from investing activities?
The current TTM CFI of ABMD is -$162.91 M
What is the all time high TTM CFI for Abiomed?
Abiomed all-time high TTM cash flow from investing activities is $26.50 M